XML 18 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities attributable to continuing operations:    
Net (loss) income and comprehensive (loss) income $ (177,548) $ 21,190
Less: Loss from discontinued operations, net of tax 4 3,516
Net (loss) income from continuing operations (177,544) 24,706
Adjustments to reconcile net (loss) income from continuing operations to net cash provided by operating activities attributable to continuing operations:    
Loss on impairments and disposal of assets 4,261 2,651
Amortization of intangibles 21,574 32,967
Depreciation 15,024 12,969
Non-cash compensation expense 47,990 51,804
Deferred income taxes 133,943 (455)
Change in fair value of contingent consideration 0 (8,249)
Gain on investments 0 (40,072)
Bad debt expense 2,708 1,823
Amortization of debt issuance costs 5,443 3,756
Write-off of previously-capitalized debt issuance costs 0 1,066
Amortization of debt discount 1,475 22,297
Reduction in carrying amount of ROU asset, offset by change in operating lease liabilities (890) 13,015
Changes in current assets and liabilities:    
Accounts receivable (1,380) (43,688)
Prepaid and other current assets (6,271) (2,762)
Accounts payable, accrued expenses and other current liabilities (19,146) 7,537
Income taxes receivable (389) 10,322
Other, net (469) (794)
Net cash provided by operating activities attributable to continuing operations 26,329 88,893
Cash flows from investing activities attributable to continuing operations:    
Capital expenditures (8,970) (30,515)
Equity investments (16,440) (1,180)
Net cash used in investing activities attributable to continuing operations (25,410) (31,695)
Cash flows from financing activities attributable to continuing operations:    
Proceeds from term loan 250,000 0
Repayment of term loan (625) 0
Repurchase of 0.625% Convertible Senior Notes (169,659) 0
Payments related to net-share settlement of stock-based compensation, net of proceeds from exercise of stock options (3,292) (6,666)
Purchase of treasury stock (43,009) 0
Payment of debt issuance costs (4) (5,995)
Payment of original issue discount on undrawn term loan 0 (2,500)
Other financing activities 0 (31)
Net cash provided by (used in) financing activities attributable to continuing operations 33,411 (15,192)
Total cash provided by continuing operations 34,330 42,006
Net cash (used in) provided by operating activities attributable to discontinued operations (7) 3,330
Total cash (used in) provided by discontinued operations (7) 3,330
Net increase in cash, cash equivalents, restricted cash and restricted cash equivalents 34,323 45,336
Cash, cash equivalents, restricted cash and restricted cash equivalents at beginning of period 251,342 170,049
Cash, cash equivalents, restricted cash and restricted cash equivalents at end of period $ 285,665 $ 215,385